racemetirosine has been researched along with Lymph Node Metastasis in 5 studies
alpha-Methyltyrosine: An inhibitor of the enzyme TYROSINE 3-MONOOXYGENASE, and consequently of the synthesis of catecholamines. It is used to control the symptoms of excessive sympathetic stimulation in patients with PHEOCHROMOCYTOMA. (Martindale, The Extra Pharmacopoeia, 30th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "For the detection of primary esophageal cancer, (18)F-FAMT-PET exhibited a sensitivity of 76." | 1.36 | 18F-FAMT-PET is useful for the diagnosis of lymph node metastasis in operable esophageal squamous cell carcinoma. ( Endo, K; Fukuchi, M; Inose, T; Kato, H; Kuwano, H; Miyazaki, T; Nakajima, M; Oriuchi, N; Sakai, M; Sano, A; Sohda, M; Suzuki, S; Tanaka, N, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sohda, M | 2 |
| Honjyo, H | 1 |
| Hara, K | 1 |
| Ozawa, D | 1 |
| Suzuki, S | 2 |
| Tanaka, N | 2 |
| Sano, A | 2 |
| Sakai, M | 2 |
| Yokobori, T | 1 |
| Inose, T | 2 |
| Miyazaki, T | 2 |
| Ojima, H | 1 |
| Higuchi, T | 2 |
| Tsushima, Y | 1 |
| Kuwano, H | 2 |
| Kaira, K | 2 |
| Oriuchi, N | 3 |
| Shimizu, K | 1 |
| Ishikita, T | 1 |
| Imai, H | 1 |
| Yanagitani, N | 2 |
| Sunaga, N | 2 |
| Hisada, T | 1 |
| Ishizuka, T | 2 |
| Kanai, Y | 1 |
| Endou, H | 1 |
| Nakajima, T | 1 |
| Endo, K | 3 |
| Mori, M | 2 |
| Kato, H | 1 |
| Nakajima, M | 1 |
| Fukuchi, M | 1 |
| Schuppert, F | 1 |
| Scheumann, GF | 1 |
| Schöber, C | 1 |
| Overbeck, J | 1 |
| Schürmeyer, TH | 1 |
| Schmoll, HJ | 1 |
| Dralle, H | 1 |
| von zur Mühlen, A | 1 |
5 other studies available for racemetirosine and Lymph Node Metastasis
| Article | Year |
|---|---|
L-[3-18F]-α-methyltyrosine accumulation as a definitive chemoradiotherapy response predictor in patients with esophageal cancer.
Topics: Aged; Aged, 80 and over; alpha-Methyltyrosine; Carcinoma, Squamous Cell; Chemoradiotherapy; Esophage | 2014 |
Evaluation of thoracic tumors with (18)F-FMT and (18)F-FDG PET-CT: a clinicopathological study.
Topics: Adult; Aged; alpha-Methyltyrosine; Antigens, CD34; Female; Fluorodeoxyglucose F18; Fusion Regulatory | 2009 |
18F-FAMT-PET is useful for the diagnosis of lymph node metastasis in operable esophageal squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; alpha-Methyltyrosine; Carcinoma, Squamous Cell; Esophageal Neoplasms | 2010 |
Assessment of therapy response in lung cancer with ¹⁸F-α-methyl tyrosine PET.
Topics: Aged; Aged, 80 and over; alpha-Methyltyrosine; Antineoplastic Combined Chemotherapy Protocols; Combi | 2010 |
[Therapy of a malignant sympathetic paraganglioma of the organ of Zuckerkandl--a case report].
Topics: Adult; alpha-Methyltyrosine; Aorta, Abdominal; Combined Modality Therapy; Dopamine; Epinephrine; Hum | 1991 |